Jeffrey Johnson possesses over 30 years of experience in multidisciplinary biotherapeutics research and development. They have held significant roles at prominent companies, including Senior Research Associate at Seattle Genetics and Principal Scientist at Celgene, contributing to advancements in antibody development, cell line optimization, and protein expression. Currently, Jeffrey serves as the Scientific Director of Biologics at ATUM, where they lead initiatives to optimize biotherapeutics processes and foster innovation. Their expertise and contributions have earned them multiple achievement awards throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices